90 related articles for article (PubMed ID: 12619576)
1. [Clinico-immunologic effect of immunomodulin and bactim in duodenal ulcer under environmental pollution conditions].
Abdullaev RB
Eksp Klin Gastroenterol; 2002; (5):42-4, 127. PubMed ID: 12619576
[TBL] [Abstract][Full Text] [Related]
2. [Experience in the use of immunomodulator likopid in ulcer disease].
Kirika NV; Bodrug NI; Butorov IV; Buturov SI; Khadzhi VV
Klin Med (Mosk); 2003; 81(11):59-62. PubMed ID: 14689714
[TBL] [Abstract][Full Text] [Related]
3. [Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
Khayat O; Kilani A; Chedly-Debbiche A; Zeddini A; Gargouri D; Kharrat J; Souissi A; Ghorbel AJ; Ben Ayed M; Ben Khelifa H
Tunis Med; 2006 Jun; 84(6):340-3. PubMed ID: 17042205
[TBL] [Abstract][Full Text] [Related]
4. [The state of immune system and effects of current therapy and immunomodulators].
Tsimmerman IaS; Mikhaleva EN
Klin Med (Mosk); 2003; 81(1):40-4. PubMed ID: 12650095
[TBL] [Abstract][Full Text] [Related]
5. Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.
El-Nakeeb A; Fikry A; Abd El-Hamed TM; Fouda el Y; El Awady S; Youssef T; Sherief D; Farid M
Int J Surg; 2009 Apr; 7(2):126-9. PubMed ID: 19138577
[TBL] [Abstract][Full Text] [Related]
6. Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer.
Suleymanov Z
Turk J Gastroenterol; 2003 Sep; 14(3):168-72. PubMed ID: 14655059
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of the different variants of the complex treatment of stomach ulcer].
Butov MA; Alebastrov AP; Kuznetsov PS; Karpova EIu
Eksp Klin Gastroenterol; 2003; (5):31-4, 193. PubMed ID: 14621607
[TBL] [Abstract][Full Text] [Related]
8. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
[TBL] [Abstract][Full Text] [Related]
9. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of different schemes of anti-helicobacter therapy in duodenal ulcer].
Kirika NV; Bodrug NI; Butorov IV; Butorov SI
Ter Arkh; 2004; 76(2):18-22. PubMed ID: 15106408
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of efficacy of eradication therapy in patients with duodenal ulcer].
Kozlova IV; Eliseev IuIu; Pakhomova AL; Khan SA
Klin Med (Mosk); 2005; 83(7):52-5. PubMed ID: 16117427
[TBL] [Abstract][Full Text] [Related]
12. [Impact of Bestim on the immunological status and clinical course of ulcer].
Tkacheva AG; Kalev OF; Dolgushina AI; Antipina TV
Eksp Klin Gastroenterol; 2004; (6):29-33, 163. PubMed ID: 16259438
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of Helicobacter pylori infection in duodenal ulcer. Data of a prospective study apropos of 78 NSAID-negative patients with duodenal ulcer].
Ben Ammar A; Cheikh I; Ouerghi H; Chaabouni H; Kchaou M; Ben Mami N
Tunis Med; 2002 Oct; 80(10):599-604. PubMed ID: 12632753
[TBL] [Abstract][Full Text] [Related]
16. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
[TBL] [Abstract][Full Text] [Related]
17. [Nonspecific resistance factors and their correction in patients with pyloroduodenal ulcer after stomach resection].
Kuliev EA; Bektashi EK; Mamedov RA; Shadlinskiĭ AB; Mamedov PS; Mamedov AM
Biull Eksp Biol Med; 1997 Nov; 124(11):574-6. PubMed ID: 9471261
[No Abstract] [Full Text] [Related]
18. [Clinical efficacy of combined anti-Helicobacter treatment of patients with duodenal ulcer].
Kirika NV; Bodrug NI; Butorov SI; Verbitskiĭ ON; Ridlovskiĭ AIu; Butorov IV; Lagutkin DI; Martyniuk LI
Klin Med (Mosk); 2003; 81(1):37-9. PubMed ID: 12650094
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the triple therapy: proton pomp inhibitors, amoxicillin and tynidazole in Helicobacter pylori infection treatment.
Kos M; Zinkiewicz K; Stefanek J; Dabrowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):161-6. PubMed ID: 12898919
[TBL] [Abstract][Full Text] [Related]
20. Differences in peripheral blood lymphocyte phenotypes between Helicobacter pylori-positive children and adults with duodenal ulcer.
Figueiredo Soares T; Aguiar Rocha G; Camargos Rocha AM; Corrêa-Oliveira R; Martins-Filho OA; Teles Carvalho AS; Souto Bittencourt PF; Afonso Oliveira C; Ferreira Nogueira AM; Alvares Cabral MM; Caetano Faria AM; Queiroz DM
Clin Microbiol Infect; 2007 Nov; 13(11):1083-8. PubMed ID: 17727687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
